SUBSCRIBE
SUBSCRIBE
News   Deals

Sanofi-Aventis (France) to Buy Dyax Corp.'s (JOBS) Drug Development Partner, Fovea Pharmaceuticals

October 13, 2009 | 
1 min read
Bookmark and Share

Reuters -- French drugmaker Sanofi-Aventis agreed to acquire Fovea Pharmaceuticals, which is jointly developing a drug with Dyax Corp to treat an eye indication.
Mergers & acquisitions
Sanofi (France)
MORE ON THIS TOPIC
Podcast
Deals Roll at JPM26, Policy Front and Center, IPOs Are Back, FDA Stays Busy
January 14, 2026
 · 
2 min read
 · 
Heather McKenzie
Businessman receiving large stacks of money from a giant hand. Concept of funding, venture capital, financial support, dividend, and profitable business.
Deals
JPM26: Attendees Wonder, Where’s Our Big M&A Deal?
January 13, 2026
 · 
2 min read
 · 
Annalee Armstrong
South San Francisco, CA, USA - May 1, 2022: Exterior view of the Merck Researches Laboratories in South San Francisco, California. Merck & Co., Inc. is a global pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme (MSD) outside the United States and Canada.
Events
JPM26: Confident Merck Sees Growth Through Keytruda Loss of Exclusivity
January 13, 2026
 · 
1 min read
 · 
Heather McKenzie
Cartoon tiny people work with scientific equipment, develop innovations, new projects ideas. Startup business teamwork, solution development through science knowledge dark concept vector illustration
Collaboration
JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy
January 12, 2026
 · 
3 min read
 · 
Annalee Armstrong